Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.36% |
| 2 | Technology | 9.28% |
| 3 | Financials | 7.68% |
| 4 | Healthcare | 6.5% |
| 5 | Industrials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
CALL
Quanta Services
PWR
$90.6B
| $5.14M | ﹤0.01% |
12,400
-4,100
| -25% | -$1.59M |
|
|
VTYX
3027
DELISTED
Ventyx Biosciences
VTYX
| $5.14M | ﹤0.01% |
1,651,794
+246,040
| +18% | +$652K |
|
3028
Univest Financial
UVSP
$1.15B
| $5.13M | ﹤0.01% |
170,857
+37,194
| +28% | +$1.14M |
|
3029
e.l.f. Beauty
ELF
$6.14B
| $5.12M | ﹤0.01% |
38,651
-26,727
| -41% | -$3.3M |
|
|
KFII
3030
K&F Growth Acquisition Corp II
KFII
| $5.1M | ﹤0.01% |
499,700
| – | – |
|
3031
Planet Labs
PL
$7.12B
| $5.1M | ﹤0.01% |
393,116
-148,072
| -27% | -$1.14M |
|
3032
B&G Foods
BGS
$286M
| $5.09M | ﹤0.01% |
1,149,955
+441,771
| +62% | +$1.93M |
|
3033
CALL
Sharplink Inc
SBET
$1.78B
| $5.08M | ﹤0.01% |
+298,900
| New | +$5.87M |
|
3034
PUT
Kohl's
KSS
$1.98B
| $5.08M | ﹤0.01% |
+330,700
| New | +$4.41M |
|
3035
PUT
United Therapeutics
UTHR
$22.1B
| $5.07M | ﹤0.01% |
+12,100
| New | +$4.07M |
|
3036
CALL
Generac Holdings
GNRC
$10.8B
| $5.07M | ﹤0.01% |
30,300
+10,100
| +50% | +$1.77M |
|
|
HOLX
3037
PUT
DELISTED
Hologic
HOLX
| $5.06M | ﹤0.01% |
+75,000
| New | +$4.98M |
|
3038
Marcus & Millichap
MMI
$1.23B
| $5.06M | ﹤0.01% |
172,267
+160,566
| +1,372% | +$5.04M |
|
3039
SkinHealth Systems
SKIN
$89.1M
| $5.05M | ﹤0.01% |
2,539,134
-701,631
| -22% | -$1.42M |
|
3040
Franklin Covey
FC
$230M
| $5.04M | ﹤0.01% |
259,618
+233,291
| +886% | +$4.62M |
|
|
OTGAU
3041
OTG Acquisition Corp I Unit
OTGAU
| $5.04M | ﹤0.01% |
+500,000
| New | +$5.02M |
|
|
SNBR
3042
DELISTED
Sleep Number
SNBR
| $5.03M | ﹤0.01% |
716,873
+656,162
| +1,081% | +$5.74M |
|
|
AMRZ
3043
Amrize Ltd
AMRZ
$24.4B
| $5.03M | ﹤0.01% |
103,639
+50,946
| +97% | +$2.6M |
|
|
SRDX
3044
DELISTED
Surmodics
SRDX
| $5.03M | ﹤0.01% |
168,263
+12,645
| +8% | +$422K |
|
3045
PUT
XPeng
XPEV
$11B
| $5.03M | ﹤0.01% |
214,700
-350,100
| -62% | -$7.03M |
|
|
GLIBK
3046
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.04B
| $5.03M | ﹤0.01% |
+134,898
| New | +$4.76M |
|
3047
CALL
Cirrus Logic
CRUS
$5.44B
| $5.02M | ﹤0.01% |
+40,100
| New | +$4.47M |
|
3048
Financial Institutions
FISI
$807M
| $5.02M | ﹤0.01% |
184,618
+93,626
| +103% | +$2.5M |
|
|
BORR
3049
Borr Drilling
BORR
$1.37B
| $5.02M | ﹤0.01% |
1,866,184
-4,772,390
| -72% | -$11.9M |
|
3050
PUT
T. Rowe Price
TROW
$23.7B
| $5.02M | ﹤0.01% |
48,900
-14,300
| -23% | -$1.5M |
|
Similar funds
Israel Englander's Q3 2025 Portfolio in Review
As of Q3 2025, Israel Englander held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Israel Englander added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Israel Englander's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Israel Englander fully exited Hess in Q3 2025, selling an estimated $478M.
- Israel Englander's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Israel Englander opened 800 new positions and closed 633 in Q3 2025.
- Israel Englander's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.